SHANGHAI y JERSEY CITY, Nueva Jersey, September 19, 2025--Shanghai Henlius Biotech, Inc. (2696.HK) y Organon (NYSE: OGN) acaban de anunciar que la Comisión Europea (CE) ha autorizado la comercializaci ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback